dual CDK2/CDK9 inhibitors (Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College)

N/A

Report date: 2025/03/19 09:01:38
NME

Base Information

Drug Namedual CDK2/CDK9 inhibitors (Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 9Cyclin-dependent kinase 2
Therapy Area/IndicationsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Medicinal Of Biotechnology Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medicinal Of Biotechnology Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsLeukemia, Myelogenous, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A